- ABMS Certification:
- Internal Medicine; Medical Oncology
- Research Interests:
Novel therapeutic approaches for urologic cancers including prostate, urothelial and kidney cancers.
- Clinical Practice:
- Adrenocortical Carcinoma, Bladder Cancer, Kidney Cancer, Prostate Cancer, Testicular Cancer, Von Hippel-Lindau Disease, Penile Cancer, Urologic Cancer
Section Chief, Medical Oncology; Deputy Director, UVA Cancer Center
Robert Dreicer, MD is deputy director of UVA Cancer Center, serves as the director of solid tumor oncology within the division of hematology/oncology and is a professor of medicine and urology.
Dr. Dreicer received his medical degree from the University of Texas-Houston and a master of science from the University of Texas Graduate School of Biomedical Sciences at Houston. Following his oncology fellowship, Dreicer joined the faculty at University of Iowa, achieving tenure and serving as the associate director of the division of hematology/oncology. He was recruited to Cleveland Clinic, where he served as chair of the department of solid tumor oncology from 2006-2014, before joining UVA Cancer Center in 2015.
Dr. Dreicer’s research interests are in novel therapeutic approaches for urologic cancers including prostate, urothelial and kidney cancers. He is co-chair of the National Cancer Institute’s Genitourinary Oncology Steering Committee and serves as member of the Medical Oncology Test Writing Committee of the American Board of Internal Medicine. He is a member of the Scientific Advisory Board of the Bladder Cancer Advocacy Network.
Dreicer has been named for many years to Top Doctors in America, America’s Best Doctors and America’s Top Doctors for Cancer. He participates regularly in national and international programs devoted to education and research in urologic malignancies.
- 2015-2018 Best Doctors in America® List
- 2015 One of America's Top Cancer Doctors, Newsweek®
- University of Texas
- Indiana University
- University of Wisconsin